This indicated that apatinib combined with PD-1 inhibitor could inhibit tumor angiogenesis by inhibiting the expression of VEGFA and VEGFR2, and then c-Myc, and the inhibitory effect was even more evident with the combined administration of CPT. Here, VEGFA is linked to neoplasm.